Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $4,400 | 1 | 47.8% |
| Food and Beverage | $3,343 | 167 | 36.3% |
| Travel and Lodging | $1,334 | 4 | 14.5% |
| Education | $99.99 | 1 | 1.1% |
| Grant | $30.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| DUSA Pharmaceuticals, Inc. | $5,824 | 9 | $0 (2019) |
| Janssen Biotech, Inc. | $552.66 | 33 | $0 (2020) |
| Allergan, Inc. | $449.27 | 19 | $0 (2021) |
| ABBVIE INC. | $430.90 | 17 | $0 (2024) |
| PFIZER INC. | $393.55 | 25 | $0 (2020) |
| GENZYME CORPORATION | $250.06 | 6 | $0 (2019) |
| Amgen Inc. | $200.07 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $187.20 | 11 | $0 (2020) |
| Genentech USA, Inc. | $116.83 | 8 | $0 (2019) |
| LEO Pharma Inc. | $116.37 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.00 | 1 | ABBVIE INC. ($30.00) |
| 2021 | $49.43 | 2 | AbbVie Inc. ($29.84) |
| 2020 | $342.44 | 10 | Janssen Biotech, Inc. ($163.12) |
| 2019 | $6,818 | 56 | DUSA Pharmaceuticals, Inc. ($5,824) |
| 2018 | $699.01 | 42 | AbbVie, Inc. ($131.02) |
| 2017 | $1,268 | 63 | PFIZER INC. ($184.10) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | ABBVIE INC. | — | Grant | Cash or cash equivalent | $30.00 | General |
| 10/15/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/15/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 07/02/2020 | Galderma Laboratories, L.P. | SOOLANTRA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ROSACEA | ||||||
| 03/11/2020 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $76.26 | General |
| 03/11/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Immunology | ||||||
| 02/26/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| 02/20/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Immunology | ||||||
| 02/19/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: IMMUNOLOGY | ||||||
| 02/18/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: DERMATOLOGY | ||||||
| 01/29/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Immunology | ||||||
| 01/08/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Inflammation | ||||||
| 12/11/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| 11/16/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| 10/22/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| 10/15/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Immunology | ||||||
| 10/10/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: BioOncology | ||||||
| 10/07/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.54 | General |
| 09/23/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $112.33 | General |
| Category: Immunology | ||||||
| 09/16/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 53 | 61 | $32,697 | $9,306 |
| 2021 | 14 | 604 | 888 | $343,054 | $63,334 |
| 2020 | 27 | 2,240 | 3,445 | $2.2M | $365,540 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Facility | 2022 | 19 | 21 | $20,618 | $5,639 | 27.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Facility | 2022 | 11 | 14 | $7,301 | $2,295 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 23 | 26 | $4,778 | $1,373 | 28.7% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 46 | 49 | $116,115 | $22,043 | 19.0% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 22 | 30 | $44,732 | $10,602 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 145 | $36,313 | $5,798 | 16.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 69 | 74 | $25,858 | $4,448 | 17.2% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 17 | 19 | $21,180 | $3,978 | 18.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 100 | 109 | $24,554 | $3,791 | 15.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 48 | $17,929 | $2,883 | 16.1% |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | Office | 2021 | 16 | 20 | $10,686 | $1,651 | 15.4% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 22 | 39 | $7,320 | $1,519 | 20.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 46 | $7,948 | $1,483 | 18.7% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 11 | 11 | $10,524 | $1,473 | 14.0% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 12 | 16 | $9,970 | $1,458 | 14.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 75 | 266 | $5,438 | $1,225 | 22.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $4,487 | $982.03 | 21.9% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2020 | 191 | 226 | $647,479 | $100,084 | 15.5% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2020 | 86 | 124 | $212,040 | $42,493 | 20.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 462 | 596 | $187,740 | $32,630 | 17.4% |
| 14060 | Tissue transfer repair of wound (10 sq centimeters or less) of eyelids, nose, ears, and/or lips | Office | 2020 | 40 | 41 | $136,858 | $26,593 | 19.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 199 | 238 | $101,626 | $18,599 | 18.3% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2020 | 30 | 31 | $83,452 | $15,629 | 18.7% |
| 14040 | Tissue transfer repair of wound (10 sq centimeters or less) of the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2020 | 24 | 24 | $77,122 | $14,951 | 19.4% |
| 17000 | Destruction of skin growth | Office | 2020 | 247 | 332 | $93,292 | $13,459 | 14.4% |
About Dr. Richard Eisen, MD
Dr. Richard Eisen, MD is a MOHS-Micrographic Surgery healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992700728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Eisen, MD has received a total of $9,207 in payments from pharmaceutical and medical device companies, with $30.00 received in 2024. These payments were reported across 174 transactions from 25 companies. The most common payment nature is "Honoraria" ($4,400).
As a Medicare-enrolled provider, Eisen has provided services to 2,897 Medicare beneficiaries, totaling 4,394 services with total Medicare billing of $438,181. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Boston, MA
- Active Since 06/17/2005
- Last Updated 09/29/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1992700728
Products in Payments
- LEVULAN KERASTICK (Drug) $5,806
- EUCRISA (Drug) $393.55
- REMICADE (Biological) $267.33
- BOTOX COSMETIC (Biological) $254.09
- Humira (Biological) $236.53
- Tremfya (Drug) $183.22
- Enbrel (Biological) $177.24
- DUPIXENT (Drug) $169.19
- COSENTYX (Biological) $147.57
- TREMFYA (Drug) $145.93
- Erivedge (Biological) $116.83
- ENSTILAR (Drug) $116.37
- Skyrizi (Biological) $112.33
- TALTZ (Drug) $95.36
- ATOPIC DERMATITIS - DISEASE (Drug) $80.87
- DUPIXENT DUPILUMAB INJECTION (Biological) $61.63
- STELARA (Biological) $43.51
- XEOMIN (Biological) $42.13
- DORYX (Drug) $35.39
- Finacea (Drug) $34.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Boston
Benjamin Solky, M.d, M.D
MOHS-Micrographic Surgery — Payments: $6,569
Dr. Katayun Adhami, M.d, M.D
MOHS-Micrographic Surgery — Payments: $257.02
Patricia Richey, Md, MD
MOHS-Micrographic Surgery — Payments: $47.01
Dr. Jessica Fewkes, M.d, M.D
MOHS-Micrographic Surgery
Molly Yancovitz
MOHS-Micrographic Surgery
Dr. Abigail Waldman, Md, MD
MOHS-Micrographic Surgery